Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Zyvox (Linezolid) Special Investigation For Vancomycin-Resistant Enterococci (VRE)(Regulatory Post Marketing Commitment Plan)

NCT01224626 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT01224626
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01224626 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Zyvox (Linezolid) Special Investigation For Vancomycin-Resistant Enterococci (VRE)(Regulatory Post Marketing Commitment Plan)
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
May 31, 2006
Completion date
April 30, 2011
Enrollment
41 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

vancomycin resistance enterococcus faecium